Clinical Trial Update: A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study assessed the combination of carboplatin, cetuximab, and RAD001 (everolimus) in advanced head and neck cancer and has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ERBITUX (cetuximab)
• RAD001 (Everolimus) (everolimus)

Snippet

Sponsor: Emory University | Conditions: Head and Neck Neoplasms, Cancer of the Head and Neck | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-12-04